Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine

Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine

Eduardo JF Lima,1,2 Maria JG Mello,1,2 Maria FPM Albuquerque,3 Maria IL Lopes,4 George HC Serra,2 Maria AZ Abreu-Lima,2 Jailson B Correia1 1Instituto de Medicina Integral Prof. Fernando Figueira - IMIP Recife; 2Faculdade, Pernambucana de Saúde - FPS Recife; 3Centro de Pesquisas Aggeu Maga...

Full description

Bibliographic Details
Main Authors:	Lima EJF, Mello MJG, Albuquerque MFPM, Lopes MIL, Serra GHC, Abreu-Lima MAZS, Correia JB
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-08-01
Series:	Pediatric Health, Medicine and Therapeutics
Online Access:	http://www.dovepress.com/clinical-and-epidemiological-characteristics-of-severe-community-acqui-peer-reviewed-article-PHMT

Similar Items

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
by: Fonseca Lima EJ, et al.
Published: (2016-06-01)

Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
by: Sandra Rodrigues da Silva, et al.

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-04-01)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
by: Irina Kislaya, et al.
Published: (2019-01-01)

Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine.
by: Silvio D Brugger, et al.
Published: (2010-07-01)

Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introduction
by: Shampa Saha, et al.
Published: (2016-12-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)

Pneumococcal serotypes causing pneumonia in the 13 valent pneumococcal conjugate vaccine era in Australian children
by: R. Strachan, et al.
Published: (2020-12-01)

Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
by: Àngela Domínguez, et al.
Published: (2017-01-01)

Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
by: Paul Turner, et al.
Published: (2015-11-01)

Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil
by: Eliane Terezinha Afonso, et al.
Published: (2013-04-01)

Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
by: Hong-Yi Lee, et al.
Published: (2018-04-01)

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis
by: Rita Reyburn, MSc, et al.
Published: (2021-01-01)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Mirjam J. Knol, et al.
Published: (2015-11-01)

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
by: Satoshi Nakano, et al.
Published: (2020-11-01)

Epidemiology of streptococcus pneumoniae post-pneumococcal conjugate vaccine introduction in South Africa
by: Von Mollendorf, Claire Emily
Published: (2017)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.
by: Jordi Càmara, et al.
Published: (2017-01-01)

Pneumococcal carriage and transmission in Karonga district, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination
by: Heinsbroek, E.
Published: (2016)

Streptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine
by: Jennie Johnstone, et al.
Published: (2011-01-01)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
by: Grossi Paolo, et al.
Published: (2005-11-01)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
by: Nicola Principi, et al.
Published: (2016-12-01)

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study
by: Claire von Mollendorf, et al.
Published: (2021-09-01)

Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
by: John Njuma Libwea, et al.
Published: (2020-09-01)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
by: Jo Southern, et al.
Published: (2018-01-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Epidemiology and population structure of serotypes 1, 5 and 7f carried by children in Portugal from 1996-2010 before introduction of the 10-valent and 13-valent pneumococcal conjugate vaccines.
by: Sónia T Almeida, et al.
Published: (2013-01-01)

Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae
by: Allison E.B. Turner, et al.
Published: (2017-03-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia.
by: Iris De Schutter, et al.
Published: (2014-01-01)

Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination
by: Derkx Véronique, et al.
Published: (2011-04-01)

Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines
by: P. V. Kulikov, et al.
Published: (2019-05-01)

Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)
by: Sicras-Mainar Antoni, et al.
Published: (2012-11-01)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
by: Nirma Khatri Vadlamudi, et al.
Published: (2020-01-01)

Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
by: Lukas Richter, et al.
Published: (2019-01-01)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
by: Nirma Khatri Vadlamudi, et al.
Published: (2020-01-01)

13-valent pneumococcal conjugate vaccine in Africa
by: Robert Cohen, et al.
Published: (2017-03-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
by: N. L. Chernaya, et al.
Published: (2012-02-01)